Start | Browse by Day | Author Index

208 Triple renin-angiotensin-aldosterone-system (RAAS) inhibition: safety and efficacy of angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor blocker (ARB), and direct renin inhibition combination therapy

Sunday, April 26, 2009
Andrea N. Traina, Pharm.D. , Albany College of Pharmacy, Albany, NY
Michael P. Kane, Pharm.D. , Albany College of Pharmacy, Albany, NY
Robert S. Busch, M.D. , The Endocrine Group, LLP, Albany, NY
Gary Bakst, M.D. , The Endocrine Group, Albany, NY
Jill M Abelseth, M.D. , The Endocrine Group, Albany, NY
Robert A. Hamilton, Pharm.D. , Albany College of Pharmacy and Health Sciences, Albany, NY
See more of: Scientific Poster Presentations Session Two
See more of: Residents and Fellows Research in Progress
<< Previous Abstract | Next Abstract >>